Amorepacific Corporation   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Seoul Korea, Republic of (1945)
Status: No NME R&D (1945)

Organization Overview

First Clinical Trial
2010
NCT01264224
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Amorepacific Corporation | Amorepacific R&D Center